Inovio Pharmaceuticals, Inc. (INO)
1.765
+0.04
(+2.02%)
USD |
NASDAQ |
Dec 30, 16:00
1.77
0.00 (0.00%)
After-Hours: 19:27
Inovio Pharmaceuticals EPS Diluted (Quarterly): -0.8721 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
| Capricor Therapeutics, Inc. | -0.5375 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.50M |
| Total Expenses (Quarterly) | 45.50M |
| Enterprise Value | 78.07M |
| Earnings Yield | -146.5% |
| Normalized Earnings Yield | -136.06 |